Inventor · disambiguated record
Nurulain Zaveri
Also filed as: ZAVERI NURULAIN · ZAVERI NURULAIN T
14 granted patents·6 pending applications·58 citations·filing 1997–2023
89Inventor score
Files withASTRAEA THERAPEUTICS LLC7STANFORD RES INST INT6ASTRAEA THERAPEUTICS INC1Astraea Therapeutics1JIANG FAMING1
Top patents by PatentIndex Score
20 records- 0183US5877166AEnantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agentsSTANFORD RES INST INT·Filed 1997·Granted Mar 2, 1999·44 cites·24 claims
- 0283US2024059664A1Piperidinyl Nociceptin Receptor CompoundsASTRAEA THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 0374USRE49825EPiperidinyl nociceptin receptor compoundsASTRAEA THERAPEUTICS LLC·Filed 2021·Granted Feb 6, 2024·0 cites·20 claims
- 0474US7109236B2Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agentsSTANFORD RES INST INT·Filed 2003·Granted Sep 19, 2006·9 cites·28 claims
- 0566US10358432B2Piperdinyl nociceptin receptor compoundsASTRAEA THERAPEUTICS LLC·Filed 2018·Granted Jul 23, 2019·0 cites·18 claims
- 0665US11827617B2Piperidinyl nociceptin receptor compoundsASTRAEA THERAPEUTICS LLC·Filed 2020·Granted Nov 28, 2023·0 cites·18 claims
- 0764US10829471B2Piperidinyl nociceptin receptor compoundsASTRAEA THERAPEUTICS INC·Filed 2019·Granted Nov 10, 2020·0 cites·15 claims
- 0864US9062042B2Nicotinic acetylcholine receptor modulatorsZAVERI NURULAIN T·Filed 2011·Granted Jun 23, 2015·1 cites·39 claims
- 0962US10112924B2Piperdinyl nociceptin receptor compoundsASTRAEA THERAPEUTICS LLC·Filed 2016·Granted Oct 30, 2018·0 cites·19 claims
- 1062US7122573B2Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agentsSTANFORD RES INST INT·Filed 2002·Granted Oct 17, 2006·2 cites·19 claims
- 1161US8697722B2Nicotinic acetylcholine receptor modulatorsJIANG FAMING·Filed 2007·Granted Apr 15, 2014·1 cites·16 claims
- 1258US10085975B2Selective high affinity α3β4 nicotinic acetylcholine receptor antagonistsASTRAEA THERAPEUTICS LLC·Filed 2017·Granted Oct 2, 2018·0 cites·18 claims
- 1357US2018318270A1Selective High Affinity Alpha3Beta4 Nicotinic Acetycholine Receptor AntagonistsASTRAEA THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 1456US7329687B2Flavanoid compounds as chemotherapeutic, chemopreventive, and antiangiogenic agentsSTANFORD RES INST INT·Filed 2003·Granted Feb 12, 2008·1 cites·32 claims
- 1549US7638554B2Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agentsSTANFORD RES INST INT·Filed 2006·Granted Dec 29, 2009·0 cites·30 claims
- 1647US2009163481A1Ppar-delta ligands and methods of their useMURPHY BRIAN J·Filed 2008·Application pending·0 cites
- 1745US9670198B2Nicotinic acetylcholine receptor modulatorsAstraea Therapeutics·Filed 2015·Granted Jun 6, 2017·0 cites·34 claims
- 1844US2014171466A1Pain management in sickle cell anemiaUNIV MINNESOTA·Filed 2013·Application pending·0 cites
- 1943US2003229136A1Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agentsFiled 2002·Application pending·0 cites
- 2042US2005228023A1Agonist and antagonist ligands of the nociceptin receptorSTANFORD RES INST INT·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nurulain Zaveri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →